4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-065101
Chief Business Development Off sold 417 shares at $59.14 ($24,661)
- Chief Business Development Off acquired 417 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BENZENO SHARON Chief Business Development Off | 2020-12-21 | Option exercise | +417 | $6.27 | $2,615 | 417 | D |
| BENZENO SHARON Chief Business Development Off | 2020-12-21 | Sale | −417 | $59.14 | $24,661 | 0 | D |
| Derivatives | |||||||
| BENZENO SHARON Chief Business Development Off | 2020-12-21 | Option exercise · Stock Option (Right to Buy) | −417 | 1,667 | D | ||
| Open-market sales · 417 sh · avg $59.14 · $24,661 | |||||||
Loading xslF345X03/doc4.xml…